SEC Form 4 · accession 0001179110-16-025261
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Schoeneck
Officer — President and CEO · Director
Period of report
May 18, 2016
Accepted (ET)
May 20, 2016 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 18, 2016 | G | 1,000 | $0.00 | D | 397,735 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Charitable donation of stock.
- F2Amount does not include 36,848 shares of common stock held directly by James A. Schoeneck.